Aytu BioPharma (NASDAQ:AYTU) Trading Up 1.4%

Aytu BioPharma, Inc. (NASDAQ:AYTU) shares shot up 1.4% during mid-day trading on Thursday . The company traded as high as $2.87 and last traded at $2.84. 7,951 shares traded hands during mid-day trading, a decline of 58% from the average session volume of 19,017 shares. The stock had previously closed at $2.80.

Aytu BioPharma Stock Up 1.4 %

The firm has a market capitalization of $15.82 million, a price-to-earnings ratio of -0.70 and a beta of -1.21. The business has a 50 day simple moving average of $3.00 and a 200-day simple moving average of $2.83. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.91 and a current ratio of 1.11.

Aytu BioPharma (NASDAQ:AYTU) last issued its earnings results on Wednesday, February 14th. The company reported ($0.04) earnings per share (EPS) for the quarter. The company had revenue of $22.93 million during the quarter. Aytu BioPharma had a negative return on equity of 41.00% and a negative net margin of 18.27%.

Aytu BioPharma Company Profile

Aytu Biopharma, Inc, a commercial-stage pharmaceutical company, focuses on commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates through two segments: Rx segment and Consumer Health segment. The Rx segment offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years and older, and Cotempla XR-ODT for patients from six to seventeen years old.